If real life were a Hollywood scriptwriter, guess who would’ve gotten all the screenplay Oscars from year to year? Yes, it ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...